A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Varenicline for Smoking Cessation

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Pharmacokinetics

• Publication date

  2010-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/11537850-000000000-00000PMID 21053991
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nicotine replacement therapy for smoking cessation.

  2012cited by this paper
• Single‐ and Multiple‐Dose Pharmacokinetics of the Selective Nicotinic Receptor Partial Agonist, Varenicline, in Healthy Japanese Adult Smokers

  2011cited by this paper
• Pharmacokinetics, Safety, and Tolerability Following Multiple Oral Doses of Varenicline Under Various Titration Schedules in Elderly Nonsmokers

  2011cited by this paper
• Quantitative Assessment of Exposure–Response Relationships for the Efficacy and Tolerability of Varenicline for Smoking Cessation

  2010cited by this paper
• Pre‐clinical properties of the α4β2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence

  2010cited by this paper
• Psychiatric Adverse Events in Randomized, Double-Blind, Placebo-Controlled Clinical Trials of Varenicline

  2010cited by this paper
• A Preliminary Benefit-Risk Assessment of Varenicline in Smoking Cessation

  2009cited by this paper
• Population pharmacokinetic analysis of varenicline in adult smokers.

  2009cited by this paper
• Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database

  2009cited by this paper
• The pharmacokinetic and tolerability profile of varenicline in healthy Chinese volunteers.

  2009cited by this paper
• Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

  2009cited by this paper
• Varenicline overdose in a teenager – a clinical pharmacology perspective

  2009cited by this paper
• Varenicline versus bupropion SR or placebo for smoking cessation: a pooled analysis.

  2008cited by this paper
• Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

  2008cited by this paper
• Varenicline in the treatment of tobacco dependence

  2008cited by this paper
• Treating Tobacco Use and Dependence: 2008 Update

  2008cited by this paper
• Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers

  2008cited by this paper
• Treating Tobacco Use and Dependence

  2008cited by this paper
• Effect of Human Renal Cationic Transporter Inhibition on the Pharmacokinetics of Varenicline, a New Therapy for Smoking Cessation: An In Vitro–In Vivo Study

  2008cited by this paper
• Translational research in medication development for nicotine dependence

  2007cited by this paper
• Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

  2007cited by this paper
• Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation.

  2007cited by this paper
• Antidepressants for smoking cessation.

  2007cited by this paper
• A double-blind study evaluating the long-term safety of varenicline for smoking cessation*

  2007cited by this paper
• Varenicline for smoking cessation

  2007cited by this paper
• Neurological Disorders: Public Health Challenges

  2007cited by this paper
• Rationale, pharmacology and clinical efficacy of partial agonists of α4β2 nACh receptors for smoking cessation

  2007cited by this paper
• Lack of Pharmacokinetic and Pharmacodynamic Interactions Between a Smoking Cessation Therapy, Varenicline, and Warfarin: An In Vivo and In Vitro Study 1

  2007cited by this paper
• Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.

  2007cited by this paper
• Efficacy of Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation A Randomized Controlled Trial

  2006cited by this paper
• Single‐Dose Pharmacokinetics of Varenicline, a Selective Nicotinic Receptor Partial Agonist, in Healthy Smokers and Nonsmokers

  2006cited by this paper
• Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial

  2006cited by this paper
• Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.

  2006cited by this paper
• Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro.

  2006cited by this paper
• Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

  2006cited by this paper
• METABOLISM AND DISPOSITION OF VARENICLINE, A SELECTIVE α4β2 ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, IN VIVO AND IN VITRO

  2006cited by this paper
• Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

  2006cited by this paper
• Pharmacokinetics, Safety, and Tolerability After Single and Multiple Oral Doses of Varenicline in Elderly Smokers

  2006cited by this paper
• Multiple‐Dose Pharmacokinetics of the Selective Nicotinic Receptor Partial Agonist, Varenicline, in Healthy Smokers

  2006cited by this paper
• Projections of Global Mortality and Burden of Disease from 2002 to 2030

  2006cited by this paper
• Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.

  2005cited by this paper
• Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.

  2005cited by this paper
• Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans.

  2005cited by this paper
• Metformin Transport by Renal Basolateral Organic Cation Transporter hOCT2

  2005cited by this paper
• Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

  2005cited by this paper
• Berichten

  2005cited by this paper
• Shape of the relapse curve and long-term abstinence among untreated smokers.

  2004cited by this paper
• Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments.

  2004cited by this paper
• Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization

  2004cited by this paper
• Cimetidine-procainamide pharmacokinetic interaction in man: Evidence of competition for tubular secretion of basic drugs

  2004cited by this paper
• Nicotine replacement therapy for smoking cessation.

  2004cited by this paper
• Principles and Clinical Application of Assessing Alterations in Renal Elimination Pathways

  2003cited by this paper
• Interactions of n-Tetraalkylammonium Compounds and Biguanides with a Human Renal Organic Cation Transporter (hOCT2)

  2002cited by this paper
• Nicotine replacement therapy for smoking cessation.

  2001cited by this paper
• Mechanisms and clinical implications of renal drug excretion*

  2001cited by this paper
• Anxiolytics and antidepressants for smoking cessation.

  2000cited by this paper
• Cigarette smoking among adults--United States, 1998.

  2000cited by this paper
• Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide.

  2000cited by this paper
• Drug Interactions with Tobacco Smoking

  1999cited by this paper
• Dose‐related cardiovascular and endocrine effects of transdermal nicotine

  1998cited by this paper
• Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs.

  1998cited by this paper
• Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine

  1998cited by this paper
• The Clinical Pharmacokinetics of Levofloxacin

  1997cited by this paper
• Pharmacokinetics of Bupropion and its Metabolites in Cigarette Smokers versus Nonsmokers

  1997cited by this paper
• Drug Administration in Patients with Renal Insufficiency

  1997cited by this paper
• Plasma Levels of Nicotine and Safety of Smokers Wearing Transdermal Delivery Systems During Multiple Simultaneous Intake of Nicotine and During Exercise

  1997cited by this paper
• The Effect of Cimetidine and Ranitidine Administration With Zidovudine

  1995cited by this paper
• The neurobiology of tobacco addiction.

  1991cited by this paper
• Special Pharmacokinetic Considerations in Children

  1987cited by this paper
• Reduction of metformin renal tubular secretion by cimetidine in man.

  1987cited by this paper
• Prediction of Creatinine Clearance from Serum Creatinine

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper
• The parameters of the ageing kidney

  1973cited by this paper
• Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males.

  1950cited by this paper

• Sex-Specific Mediation of Pre-Quit Smoking Reduction: Secondary Analysis of a Randomized Controlled Trial Extending Varenicline Preloading

  2025cites this paper
• Use of low-dose varenicline in patients who do not tolerate standard-dose varenicline: A longitudinal case series

  2025cites this paper
• Mitophagy in perioperative neurocognitive disorder: mechanisms and therapeutic strategies

  2025cites this paper
• Drug-Induced Autoimmune Hepatitis by Varenicline and Infliximab as a Continuous Disease Spectrum with Two Different Flares: Acute Liver Injury Followed by Hepatic Autoimmunity

  2025influential citation
• Method development and validation of varenicline in plasma samples of patients under smoking cessation treatment

  2024cites this paper
• Inhibition of sensory neuron driven acute, inflammatory, and neuropathic pain using a humanised chemogenetic system

  2023cites this paper
• Past and current drug repurposing clinical trials to treat cognition in methamphetamine use: a scoping review of pharmacotherapy candidates

  2023cites this paper
• A humanized chemogenetic system inhibits murine pain-related behavior and hyperactivity in human sensory neurons

  2023cites this paper
• Psychopharmacology of smoking cessation medications: focus on patients with mental health disorders

  2023cites this paper
• A scoping review of smoking cessation pharmacogenetic studies to advance future research across racial, ethnic, and ancestral populations

  2023cites this paper
• Effects of varenicline on the serum levels of olanzapine in male patients with Schizophrenia: a randomized controlled trial

  2023cites this paper
• Varenicline Mitigates the Increased Risk of Pseudoarthrosis Associated with Nicotine.

  2023cites this paper
• Medication Adherence in Tobacco Cessation Clinical Trials.

  2023cites this paper
• Competitive inhibition of nicotine acetylcholine receptors using microneedles of nicotine and varenicline for smoking withdrawal therapy.

  2023cites this paper
• Online biological sample preparation with restricted access hybrid carbon nanotubes for determination of anti-smoking drugs.

  2022cites this paper
• Nanomicelles-in-coaxial nanofibers with exit channels as a transdermal delivery platform for smoking cessation.

  2022cites this paper
• Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes

  2022cites this paper
• Alcohol Drinking, Smoking, and Diabetes

  2022cites this paper
• Three Mutations Convert the Selectivity of a Protein Sensor from Nicotinic Agonists to S-Methadone for Use in Cells, Organelles, and Biofluids

  2022cites this paper
• Semi-PBPK Modeling and Simulation to Evaluate the Local and Systemic Pharmacokinetics of OC-01(Varenicline) Nasal Spray

  2022influential citation
• Stability of varenicline concentration in saliva over twenty-one days at three storage temperatures.

  2021cites this paper
• A Phase I, Open-Label, Randomized, 2-Way Crossover Study to Evaluate the Relative Bioavailability of Intranasal and Oral Varenicline.

  2021cites this paper
• Population pharmacokinetics and exposure–response analyses of varenicline in adolescent smokers

  2021cites this paper
• The Role of Pharmacogenetics in Smoking

  2021cites this paper
• Recent Updates of Pharmacotherapy for Smoking Cessation

  2021cites this paper
• Automated Solid Phase Extraction and Polarity-Switching Tandem Mass Spectrometry Technique for High Throughput Analysis of Urine Biomarkers for 14 Tobacco-related Compounds

  2021cites this paper
• Varenicline for the Treatment of Cocaine Dependence

  2021cites this paper
• Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation

  2021cites this paper
• α4β2* Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait–Balance Disorders

  2021cites this paper
• Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism

  2020cites this paper
• Nicotine and Cardiovascular Function

  2020cites this paper
• Smoking Cessation: Breaking the Strong Addiction

  2020cites this paper
• Barriers and Facilitators of Adherence to Nicotine Replacement Therapy: A Systematic Review and Analysis Using the Capability, Opportunity, Motivation, and Behaviour (COM-B) Model

  2020cites this paper
• Agents for Treatment of Withdrawal and Dependency: Varenicline

  2020cites this paper
• Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations

  2020cites this paper
• Solar-light promoted photodegradation of metronidazole over ZnO-ZnAl2O4 heterojunction derived from 2D-layered double hydroxide structure

  2020cites this paper
• The two-way relationship between nicotine and cortical activity: a systematic review of neurobiological and treatment aspects

  2020cites this paper
• alpha4beta2* Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease

  2020cites this paper
• Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry

  2019cites this paper
• The relationship of varenicline agonism of α4β2 nicotinic acetylcholine receptors and nicotine-induced dopamine release in nicotine dependent humans.

  2019cites this paper
• Mirtazapine decreased induction and expression of cocaine + nicotine-induced locomotor sensitisation in rats

  2019cites this paper
• Impact of Early Nausea on Varenicline Adherence and Smoking Cessation.

  2019cites this paper
• Effects of chronic treatment with bupropion on self-administration of nicotine + cocaine mixtures in nonhuman primates.

  2019cites this paper
• Influence of body weight and UGT2B7 polymorphism on varenicline exposure in a cohort of smokers from the general population

  2019cites this paper
• Prolonged exposure of rats to varenicline increases anxiety and alters serotonergic system, but has no effect on memory.

  2019cites this paper
• Exploring the interoceptive stimulus effects of nicotine and varenicline.

  2019cites this paper
• Immediate release tablet formulation of varenicline salicylate and comparative pharmacokinetic study in human volunteers

  2018cites this paper
• Evaluation of Prolonged Exposure to Varenicline in Adult Rats: Haematological, Biochemical and Anatomopathological Studies

  2018cites this paper
• Proposal of open field test as a model of varenicline pharmacokinetic study in rats

  2018cites this paper
• Tobacco Smoking Addiction: Epidemiology, Genetics, Mechanisms, and Treatment

  2018cites this paper
• Management, Pharmacotherapies, and Precision Medicine for Smoking Cessation

  2018cites this paper
• immediate release tablet formulation of varenicline salicylate and comparative pharmacokinetic study in human volunteers

  2018cites this paper
• Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes.

  2018cites this paper
• Smoking resumption after heart or lung transplantation: a systematic review and suggestions for screening and management.

  2018cites this paper
• The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data

  2018cites this paper
• Renal Drug Transporters and Drug Interactions

  2017cites this paper
• Selective and regulated trapping of nicotinic receptor weak base ligands and relevance to smoking cessation

  2017influential citation
• Compromised neuroplasticity in cigarette smokers under nicotine withdrawal is restituted by the nicotinic α4β2-receptor partial agonist varenicline

  2017cites this paper
• Involvement of Proton-Coupled Organic Cation Antiporter in Varenicline Transport at Blood-Brain Barrier of Rats and in Human Brain Capillary Endothelial Cells.

  2017cites this paper
• Pharmacogenetic Optimization of Smoking Cessation Treatment.

  2017cites this paper
• Measures and predictors of varenicline adherence in the treatment of nicotine dependence.

  2017influential citation
• Evaluating the Real-World Effectiveness of Bupropion Versus Varenicline for Smoking Cessation: Exploring the Role of Nicotine Metabolism and Medication Adherence

  2017cites this paper
• Effects of varenicline on cognitive function in non-smokers with schizophrenia.

  2017cites this paper
• Sleep Disturbance During Smoking Cessation: Withdrawal or Side Effect of Treatment?

  2017cites this paper
• Effect of varenicline on colonic motility in a rat model of experimental irritable bowel

  2017cites this paper
• Aggravation of Acute Adrenal Crisis Due to Varenicline in a Patient with Adrenal Insufficiency

  2016cites this paper
• Sex Differences in Smoking Cessation Pharmacotherapy Comparative Efficacy: A Network Meta-analysis

  2016cites this paper
• The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders.

  2016cites this paper
• Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products

  2016cites this paper
• Effects of varenicline on alpha4-containing nicotinic acetylcholine receptor expression and cognitive performance in mice.

  2016cites this paper
• Effect of Lowering the Dose of Varenicline on Alcohol Self-administration in Drinkers With Alcohol Use Disorders

  2016cites this paper
• Anti-addiction Agents

  2016cites this paper
• Sources of Variation in Nicotine Metabolism and Associations with Smoking Abstinence in Adolescents and Adults

  2016cites this paper
• Varenicline-Induced Elevation of Dopamine in Smokers: A Preliminary [11C]-(+)-PHNO PET Study

  2016cites this paper
• Clinically Significant Interactions with Anti-addiction Agents

  2016cites this paper
• Physiological scaling factors and mechanistic models for prediction of renal clearance from in vitro data

  2016cites this paper
• The Effects of Varenicline on Neurocognitive Function in Non-smokers with Schizophrenia

  2016cites this paper
• Substance Related and Addictive Disorders

  2015cites this paper
• "Principal Component Analysis and the Cumulative Gait Index: Translational Tools to Assess Gait Impairments in Rats with Olivocerebellar Ataxia"

  2015cites this paper
• Pharmacokinetic-pharmacodynamic modeling of the effect of varenicline on nicotine craving in adult smokers.

  2015cites this paper
• Emerging areas of research in the assessment of pharmacokinetics in patients with chronic kidney disease

  2015influential citation
• Varenicline‐induced acute liver injury with jaundice

  2015cites this paper
• Effect of the Nicotinic α4β2-receptor Partial Agonist Varenicline on Non-invasive Brain Stimulation-Induced Neuroplasticity in the Human Motor Cortex.

  2015cites this paper
• Short-term effects of varenicline therapy on homogeneity of heart rate, atrioventricular conduction and ventricular repolarization

  2015cites this paper
• A Discussion about Modalities of Smoking Cessation in Perioperative Phase for Addicts: A Review Article

  2014cites this paper
• A Comparison of the Pharmacokinetics and Drug Safety Among East Asian Populations

  2014cites this paper
• Role of nicotine receptor partial agonists in tobacco cessation

  2014cites this paper
• Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent users.

  2014cites this paper
• On-line column coupled isotachophoresis-capillary zone electrophoresis hyphenated with tandem mass spectrometry in drug analysis: varenicline and its metabolite in human urine.

  2014cites this paper
• Larval Zebrafish Model for FDA-Approved Drug Repositioning for Tobacco Dependence Treatment

  2014cites this paper
• Effects of Chronic Varenicline Treatment on Nicotine, Cocaine, and Concurrent Nicotine+Cocaine Self-Administration

  2014cites this paper
• Pharmacological and Integrated Treatments in Older Adults with Substance Use Disorders

  2014cites this paper
• Functional interactions of varenicline and nicotine with nAChR subtypes implicated in cardiovascular control.

  2014cites this paper
• [Smoking cessation in case of chronic kidney disease].

  2013cites this paper
• Effects of varenicline on abstinence and smoking reward following a programmed lapse.

  2013cites this paper
• Prediction of clinical drug-drug interactions of veliparib (ABT-888) with human renal transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K).

  2013cites this paper
• Up in Smoke? A Preliminary Open-Label Trial of Nicotine Replacement Therapy and Cognitive Behavioral Motivational Enhancement for Smoking Cessation Among Youth in Los Angeles

  2013cites this paper
• Effects of Short-Term Varenicline Administration on Emotional and Cognitive Processing in Healthy, Non-Smoking Adults: A Randomized, Double-Blind, Study

  2013influential citation
• Effects of short-term varenicline administration on cortisol in healthy, non-smoking adults: a randomized, double-blind, study

  2013cites this paper
• Varenicline and nicotine enhance GABAergic synaptic transmission in rat CA1 hippocampal and medial septum/diagonal band neurons.

  2013cites this paper